Rajesh Exports SEBI order: ₹15 lakh crore revenue row
Why Rajesh Exports is trending now
Rajesh Exports Ltd is being discussed widely after SEBI issued an interim order against it. Social media focus has been on the size of the alleged revenue issue. The regulator’s action also covers the company’s promoter and chairman, Rajesh Mehta. Reports say SEBI has restrained both from accessing the securities market pending investigation. The order has triggered debates about disclosures and governance in listed companies. It has also revived questions about how subsidiary numbers get consolidated. Rajesh Exports has publicly denied wrongdoing in responses cited by media. The company has also said it will cooperate with a fresh forensic audit.
What SEBI’s interim order alleges
SEBI’s interim ex-parte order is described as a 109-page document. The order was issued on June 3, 2026, according to the widely shared reports. It was issued by Whole Time Member Kamlesh Chandra Varshney, as cited in coverage. SEBI’s interim findings allege large-scale financial misstatements at Rajesh Exports. The regulator also points to possible fund diversion through promoter-linked entities. Another allegation is that some transactions were non-genuine in nature. SEBI also flags suspected misclassification of personal transactions as corporate sales. SEBI’s findings are described as prima facie and part of an ongoing investigation.
The ₹15.15 lakh crore figure explained
The headline number discussed online is ₹15.15 lakh crore of alleged misrepresentation. SEBI’s interim view is that this amount relates to consolidated revenues between FY21 and FY25. Multiple reports state the alleged misstatement aggregates to about ₹15,15,385 crore. The regulator’s order suggests this could represent about 99.8% of reported consolidated revenue. Social posts often translate this into an allegation that 97% to 99% of revenue may be questionable. SEBI’s case, as reported, hinges on revenues that could not be reconciled with available records. The allegations have been framed as a revenue misstatement rather than a minor classification issue. The company has rejected this interpretation and defended its financial reporting.
Focus on overseas subsidiaries and disclosures
A central point in SEBI’s interim order relates to overseas subsidiaries. Coverage highlights Switzerland-based Valcambi SA as a key subsidiary referenced. SEBI alleges that a large share of consolidated income came from subsidiaries and branches. Reports put this share in the 97% to 99% range for the years cited. SEBI’s concern, as described, is that subsidiary financials were not disclosed in a way the regulator expected. The order also notes difficulty reconciling revenues with records available at the subsidiary level. That gap is what drives the allegation that revenues lacked backing. The episode has prompted retail investors to ask how cross-border consolidation is verified. It has also led to discussion about whether disclosures were adequate for such a subsidiary-heavy profile.
Allegations on fund diversion and personal trades
Beyond revenue, SEBI’s interim findings refer to possible fund diversion. Reports say the regulator suspects routing of funds through promoter-linked entities. Another repeated allegation is that personal transactions were shown as corporate sales. SEBI has also alleged the promoter may have used company funds for personal stock market bets. The interim order is framed as identifying patterns of questionable accounting and non-genuine transactions. Social media discussions have treated these points as corporate governance red flags. At the same time, the company’s side has pushed back strongly in public statements. It is important to note that these are allegations in an interim order. The investigation outcome and forensic audit findings will be key to confirmation.
What the company and Rajesh Mehta say
Rajesh Exports has denied SEBI’s allegations in statements reported by media. Chairman Rajesh Mehta has also rejected the claim that the company impeded the audit. He has said that all requested documents were submitted to the regulator. In one reported quote, he described the SEBI order as interim and said nothing in it is true. The company has maintained that its declared revenues are accurate. It has also said it will cooperate with the newly ordered forensic audit. This stance has been repeated across multiple social posts sharing news links. The denial has not changed the interim restraints described in the order. Investors are therefore watching for what the forensic audit process uncovers next.
Forensic audit next steps and what it means
SEBI has ordered a fresh forensic audit, as repeatedly referenced in coverage. Rajesh Exports has said it will cooperate with this process. A forensic audit typically aims to test transaction-level evidence against reported figures. In this case, social media focus is on whether subsidiary revenues can be reconciled. The audit is also expected to examine whether transactions were genuine, based on the regulator’s concerns. Since SEBI’s order is interim, the process is still developing. Market participants are watching for any further regulatory directions or clarifications. Many posts also mention that the allegations span multiple years from FY21 to FY25. Until the investigation concludes, uncertainty is likely to remain a key overhang.
Listed status, trading restraints, and investor watchpoints
Rajesh Exports is described in widely shared posts as listed on both NSE and BSE. The current controversy is therefore being debated as a listed-company governance issue. SEBI’s interim order, as reported, restrains the company and Rajesh Mehta from accessing the securities market. Reports also say Mehta has been barred from trading in the company’s securities. Separately, social posts cite a sharp market reaction after the order. Coverage mentions the stock hit a 5% lower circuit for two consecutive sessions. Investors are also discussing what a market-access restraint means in practice. The key watchpoints now are the forensic audit, SEBI’s final findings, and any subsequent orders. Until then, the situation remains a regulatory investigation with contested claims.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
